Patents Assigned to SCIENTIFIQUE (CNRS)
-
Patent number: 11440932Abstract: The present invention relates to a compound of formula (I): (I) as defined in the description. The present invention also relates to a method for extracting biological membrane-associated membrane proteins, comprising a step of bringing an aqueous solution of biological membrane-associated membrane proteins into contact with at least one compound of the invention. The present invention also relates to a method for stabilizing membrane proteins in solution in an aqueous solution, comprising a step (i) consisting in bringing an aqueous solution of a membrane protein in solution into contact with at least one compound of the invention.Type: GrantFiled: December 27, 2017Date of Patent: September 13, 2022Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE CLAUDE BERNARD LYON 1, UNIVERSITE GRENOBLE ALPESInventors: Pierre Falson, Julien Dauvergne, Ahcène Boumendjel, Marine Peuchmaur, Kim Anh Nguyen, Sandrine Magnard
-
Publication number: 20220279814Abstract: A protein hydrolysate obtained from at least one protein source from bluefish having (i) a degree of hydrolysis (DH) of at least 10%, (ii) at least 80% water-soluble protein with a molecular weight of less than 1000 Da, (iii) at least 0.3% phospholipids, and (iv) at least 0.5% DHA and EPA.Type: ApplicationFiled: July 31, 2020Publication date: September 8, 2022Applicants: SPECIALITES PET FOOD, UNIVERSITE DE BORDEAUX, UNIVERSITÉ DE BRETAGNE OCCIDENTALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD), INSTITUT POLYTECHNIQUE DE BORDEAUX, ABYSS INGREDIENTS, INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER - IFREMER, INSTITUT NATIONAL DE LA RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENTInventors: Fabienne GUERARD, Cloé OROY, Anne LEPOUDERE, Mathilde CHATAIGNER, Patrick ALLAUME, Anne-Laure DINEL, Corinne JOFFRE, Véronique PALLET, Fabienne LE GRAND
-
Publication number: 20220280498Abstract: The present invention relates to compounds of formula (I): for use as peripheral NMDA receptor antagonists.Type: ApplicationFiled: May 26, 2022Publication date: September 8, 2022Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE PARIS SUD, ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (APHP), HOPITAL MARIE LANNELONGUEInventors: Sylvia COHEN-KAMINSKY, Marc HUMBERT, Sebastien DUMAS, Gilles BRU-MERCIER, Samir MESSAOUDI, Jean-Daniel BRION, Mouad ALAMI, Gilles GALVANI
-
Publication number: 20220280683Abstract: A composition based on triblock copolymers of the ABA type, including two styrene thermoplastic terminal blocks A, and an elastomer central block B which is a saturated olefin, and at least one polyisobutene having a very low molecular weight and optionally a diblock copolymer of AB. The present composition exhibits advantageous properties which are similar to those of silicone elastomers. Also, a dressing including such an elastomeric composition.Type: ApplicationFiled: July 30, 2020Publication date: September 8, 2022Applicants: URGO RECHERCHE INNOVATION ET DEVELOPPEMENT, UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -Inventors: Christophe DERAIL, Armelle RONCIN, Xavier CALLIES, Christelle Marie Aline GUILLAMAUD, Anne-Sophie DANEROL, Marie DAUX
-
Patent number: 11434882Abstract: Disclosed is a device including at least one circulating zone and at least one fluid including at least one more-paramagnetic liquid and at least one less-paramagnetic liquid forming a liquid-liquid interphase, the device including at least one element generating, in the circulating zone, a magnetic field, wherein the less-paramagnetic liquid is surrounded by the more-paramagnetic liquid in the circulating zone or wherein the more-paramagnetic liquid is surrounded by the less-paramagnetic liquid in the circulating zone. Also disclosed is a method including circulating at least one less-paramagnetic liquid inside one or more circulating zones of a device including at least one circulating zone and at least one more-paramagnetic liquid in the circulating zone.Type: GrantFiled: January 19, 2018Date of Patent: September 6, 2022Assignees: UNIVERSITÉ DE STRASBOURG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH COLLEGE GREENInventors: Thomas Hermans, John Michael David Coey, Peter Dunne, Bernard Doudin
-
Patent number: 11434585Abstract: The present invention pertains to the field of protein engineering, and provides means for obtaining stable molecules that specifically bind to a target selected amongst a large variety of ligands families. In particular, the present invention provides methods for obtaining a molecule specifically binding to a target of interest, through a combinatorial mutation/selection approach with an OB-fold protein as a starting molecule. In particular, the target of interest can be of a different chemical nature form that of the native target of the OB-fold protein used as the starting molecule.Type: GrantFiled: January 24, 2020Date of Patent: September 6, 2022Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Frédéric Pecorari, Pedro Alzari
-
Patent number: 11434253Abstract: Enantiopure terphenyl presenting two ortho-located chiral axes having the following structural formula (I): their process of synthesis and their use as mono or bidentate ligands for asymmetric organometallic reactions, as organocatalysts, as chiral base and as generator, with metal, of isolable chiral metallic complexes for applications in asymmetric catalysis and others.Type: GrantFiled: December 12, 2018Date of Patent: September 6, 2022Assignees: UNIVERSITE DE STRASBOURG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Quentin Dherbassy, Joanna Wencel-Delord, Françoise Colobert, Gaspard Hedouin
-
Publication number: 20220275227Abstract: The present invention concerns a process for preparing in situ an aqueous gel ink with fixed color comprising the following steps: (i) preparing a gel-based matrix of aqueous ink comprising ester(s) of retinol represented by formula (I), and (ii) adding a solution of gold salts (Au3+) to the gel-based matrix of aqueous ink prepared in step (i), to obtain an aqueous gel ink with fixed color with gold nanoparticles dispersed therein. The present invention also relates to an aqueous gel ink with fixed color obtained according to the process of the invention, comprising said ester of retinol represented by formula (I) and gold nanoparticles. The invention finally concerns a writing instrument comprising an aqueous gel ink with fixed color according to the invention.Type: ApplicationFiled: August 28, 2020Publication date: September 1, 2022Applicants: SOCIETE BIC, UNIVERSITE DE HAUTE ALSACE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Olivier ALBENGE, Romain METILLON, Karine MOUGIN, Feriel GHELLAL, Arnaud SPANGENBERG
-
Publication number: 20220275226Abstract: The present invention concerns a process for preparing in situ an aqueous gel ink with fixed color comprising the following steps: (i) preparing a gel-based matrix of aqueous ink comprising reducing agent chosen in the group consisting of citric acid and/or derivatives of citric acid, (ii) adding a solution of gold salts, (iii) adding iron powder, (iv) adding polyvinylpyrrolidone to obtain an aqueous gel ink with fixed color, wherein the steps (ii) and (iii) can be interchanged. The present invention also relates to an aqueous gel ink with fixed color obtained according to the process of the invention, comprising citric acid and derivatives, gold nanoparticles, and iron powder. The invention finally concerns a writing instrument comprising an aqueous gel ink with fixed color according to the invention.Type: ApplicationFiled: August 28, 2020Publication date: September 1, 2022Applicants: SOCIETE BIC, UNIVERSITE DE HAUTE ALSACE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Olivier ALBENGE, Romain METILLON, Karine MOUGIN, Feriel GHELLAL, Arnaud SPANGENBERG
-
Publication number: 20220273582Abstract: A continuous process for nano-emulsification that is performed by concentration phase inversion in a microfluidic reactor, including the following steps: (a) injection of an aqueous phase into a first microchannel, the first microchannel opening onto a formulation chamber, (b) injection, into a second microchannel, of a fatty phase including one or more fatty substances immiscible in the aqueous phase, and one or more surfactants, the second microchannel opening into the formulation chamber, then (c) mixing of the aqueous phase and the fatty phase in the formulation chamber, then (d) recovering, at the output of the formulation chamber, a suspension including lipid nanocapsules. Also, the lipid nanocapsules obtainable by the process, and the use of the lipid nanocapsules as nanovectors for pharmacologically active ingredients.Type: ApplicationFiled: July 24, 2020Publication date: September 1, 2022Applicants: UNIVERSITÉ D'ANGERS, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Brice CALVIGNAC, Jean-Christophe GIMEL, Emilie ROGER, Nicolas ROLLEY, Guillaume LEFEBVRE, Guillaume BASTIAT, Florian FOUCHET, Kévin MATHA
-
Publication number: 20220275229Abstract: The invention relates a process for preparing an aqueous gel ink with fixed color comprising the following steps: (i) preparing a gel-based matrix of aqueous ink; (ii) preparing an aqueous suspension of gold or silver nanoparticles with a fixed color; (iii) adding the aqueous suspension of gold or silver nanoparticles obtained in step (ii) to the gel-based matrix of aqueous ink obtained in step (i).Type: ApplicationFiled: August 28, 2020Publication date: September 1, 2022Applicants: SOCIETE BIC, UNIVERSITE DE HAUTE ALSACE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Olivier ALBENGE, Romain METILLON, Karine MOUGIN, Feriel GHELLAL, Arnaud SPANGENBERG
-
Publication number: 20220273841Abstract: A bone cement composition including a powder component, a liquid component, and hyaluronic acid (HA) or a salt thereof in an amount ranging from 0.01% to 10% w/w in the powder component and/or in the liquid component. The powder component includes calcium phosphate compounds having at least alpha-tricalcium phosphate (?-TCP) and having at least calcium-deficient apatite (CDA). Also, a bone cement obtainable by a process including the following steps: (i) the preparation of a cement composition by mixing the powder component, and the liquid component and (ii) the setting of the cement composition. Further, the use in vitro or ex vivo of a bone cement composition or bone cement in the manufacture of a dental or bony implant.Type: ApplicationFiled: July 17, 2020Publication date: September 1, 2022Applicants: GRAFTYS, UNIVERSITE DE NANTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Enrico Javier BASTIANELLI, Jean-Michel BOULER, Bruno BUJOLI
-
Publication number: 20220275228Abstract: The present invention concerns a process for preparing in situ an aqueous gel ink with variable color comprising the following steps: (i) preparing a gel-based matrix of aqueous ink comprising an N-Acyl-aminophenol, wherein said hydroxyl group is preferably in meta or in para position on the benzenic group, and (ii) adding a solution of silver salts to the gel-based matrix of aqueous ink prepared in step (i), to obtain an aqueous gel ink with variable color with silver nanoparticles dispersed therein. The present invention also relates to an aqueous gel ink with variable color obtained according to the process of the invention, comprising an N-Acyl-aminophenol, wherein said hydroxyl group is preferably in meta or in para position on the benzenic group and silver nanoparticles. The invention finally concerns a writing instrument comprising an aqueous gel ink with variable color according to the invention.Type: ApplicationFiled: August 28, 2020Publication date: September 1, 2022Applicants: SOCIETE BIC, UNIVERSITE DE HAUTE ALSACE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Olivier ALBENGE, Romain METILLON, Karine MOUGIN, Feriel GHELLAL, Arnaud SPANGENBERG
-
Publication number: 20220275225Abstract: The present invention concerns a process for preparing an aqueous gel ink with fixed color comprising the following steps: (i) preparing a gel-based matrix of aqueous ink; (ii) preparing an aqueous suspension of silver nanoparticles with a fixed color by mixing silver salts with: —water, —a mixture of at least an alkali metal or alkaline earth metal salt of citrate, —an oxidizing agent, preferably hydrogen peroxide H2O2, —and polyvinylpyrrolidone; (iii) adding under agitation the aqueous suspension of silver nanoparticles obtained in step (ii) to the gel-based matrix of aqueous ink obtained in step (i), to obtain an aqueous gel ink with fixed color with silver nanoparticles dispersed therein.Type: ApplicationFiled: August 28, 2020Publication date: September 1, 2022Applicants: SOCIETE BIC, UNIVERSITE DE HAUTE ALSACE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Olivier ALBENGE, Romain METILLON, Karine MOUGIN, Feriel GHELLAL, Arnaud SPANGENBERG
-
Publication number: 20220275230Abstract: The present invention concerns a process for preparing an aqueous gel ink with fixed color comprising the following steps: (i) preparing a gel-based matrix of aqueous ink; (ii) preparing an aqueous suspension of silver nanoparticles with fixed color by mixing silver salts with: water, a mixture of at least an alkali metal or alkaline earth metal salt of citrate, preferably an alkali citrate salt and an alkali metal hydride, preferably NaBH4, a further reducing agent, preferably ascorbic acid, and oxidizing agent, preferably hydrogen peroxide H2O2 (iii) adding under agitation the aqueous suspension of silver nanoparticles obtained in step (ii) to the gel-based matrix of aqueous ink obtained in step (i), to obtain an aqueous gel ink with fixed color with silver nanoparticles dispersed thereinType: ApplicationFiled: August 28, 2020Publication date: September 1, 2022Applicants: SOCIETE BIC, UNIVERSITE DE HAUTE ALSACE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Olivier ALBENGE, Romain METILLON, Karine MOUGIN, Feriel GHELLAL, Arnaud SPANGENBERG
-
Publication number: 20220273850Abstract: A three-dimensional biomaterial including particles encapsulating at least one complement active fragment dispersed therein. Also, a process of manufacturing of the three-dimensional biomaterial with at least one biocompatible and/or resorbable polymer and the particles. The three-dimensional biomaterial is useful for tissue regeneration, especially with regards to dental pulp, dentin, periodontal and gingival tissues, as well as bones tissues.Type: ApplicationFiled: July 31, 2020Publication date: September 1, 2022Applicants: SEPTODONT OU SEPTODONT SAS OU SPECIALITES SEPTODONT, UNIVERSITÉ D'AIX MARSEILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Imad ABOUT, Gilles RICHARD, Madison BERGMANN, Charlotte JEANNEAU, Mounir DJOUDI
-
Publication number: 20220275420Abstract: A biomass-based enzymatic biocathode based on glucose, monosaccharide, ketone or aldehyde includes a collector conductor support, conductive particles disposed on and bound to said collector conductor support, and an aldose reductase disposed on said conductive particles, being bound thereto by adsorption and accessible at the surface of the monosaccharide, ketone or aldehyde reagent that is to be reduced when the biocathode is operational.Type: ApplicationFiled: July 27, 2020Publication date: September 1, 2022Applicants: UNIVERSITÉ GRENOBLE ALPES, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MEDICALE - INSERM, GRENOBLE INP (INSTITUT NATIONAL POLYTECHNIQUE), CNRS - CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Abdelkader ZEBDA, Philippe CINQUIN, Donald MARTIN, Thomas SORANZO
-
Patent number: 11428924Abstract: According to one aspect, the invention relates to a device for transporting and controlling light beams for endo-microscopic imaging without a lens on the distal side comprising a single-mode optical fibre bundle (40) on the distal side, wherein each single-mode optical fibre is intended to receive an elementary light source and to emit a light beam at a distal end; a single-mode optical fibre section (50) arranged at the distal end of the optical fibre bundle and intended to receive the light beams emitted by the single-mode optical fibres of the optical fibre bundle; an optical phase control device arranged on the side of the proximal end of the single-mode optical fibres.Type: GrantFiled: April 4, 2017Date of Patent: August 30, 2022Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, Ecole Centrale de Marseille (ECM), Université d'Aix-Marseille (AMU)Inventors: Hervé Rigneault, Esben Ravn Andresen, Siddarth Sivankutty
-
Patent number: 11426704Abstract: The use of porous crystalline solids constituted of a metal-organic framework (MOF) for the capture of polar volatile organic compounds (VOCs). In particular, the MOF of interest are material having an average pores sizes of 0.4 to 0.6 nm and an hydrophobic core formed by a metal oxide and/or hydroxide network connected by linkers, the linkers being selected from the group including (i) C6-C24 aromatic polycarboxylate linkers, such as benzyl or naphtyl di-, tri- or tetracarboxylate, and (ii) C6-C16 polycarboxylate aliphatic linkers; the linkers bearing or not apolar fluorinated groups, e.g. —(CF2)n—CF3 groups, n being a integer from 0 to 5, preferably 0 ou 3, and/or apolar C1-C20 preferably C1-C4 alkyl groups, e.g. —CH3 or —CH2—CH3, grafted directly to the linkers and pointing within the pores of the MOF.Type: GrantFiled: September 12, 2018Date of Patent: August 30, 2022Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE NORMALE SUPERIEURE DE PARIS, ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS, UNIVERSITÉ DE VERSAILLES—SAINT-QUENTIN-EN-YVELINES, INSTITUTO SUPERIOR TÉCNICOInventors: Christian Serre, Moisés L. Pinto
-
Patent number: 11427566Abstract: A compound of formula (I): wherein A and A? independently represent a phenylene group or a pyridylene group; R2 is a hydrogen atom or a (C1-C4)alkyl group; R3 is a 2-pyridyl group, 3-pyridyl group, a 4-pyridyl group, a 2-pyrimidinyl group, a 4-pyrimidinyl group or a 5-pyrimidinyl group; R4 is a carbonyl group or a sulfonyl group; and R5 is a —NH—(CH2)a—NR6R7 group or a 4-methylpiperazinyl group, with a being an integer from 1 to 4, R6 and R7 representing independently a (C1-C4)alkyl group, or R6 and R7 together with the nitrogen atom to which they are linked forming a heterocycle group which is chosen among a 4-methylpiperazinyl group, a morpholino group, a pyrrolidinyl group and a piperidino group; or any one of its pharmaceutically acceptable salt.Type: GrantFiled: April 15, 2020Date of Patent: August 30, 2022Assignees: ABIVAX, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT CURIE, UNIVERSITE DE MONTPELLIERInventors: Pierre Roux, Florence Mahuteau, Romain Najman, Gilles Gadea, Jamal Tazi, Didier Scherrer, Carsten Brock, Nathalie Cahuzac